many months back shares vanda pharmaceuticals going bucks i warned y'all main product iloperidone showed signs dud clinical trials stage development decade yet receive fda approval um drug significant benefit really think would late stage development years december i wrote iloperidone one article forecasted would hit market digging indicated titan holds license iloperidone extent anyway spot trouble allegedly hiding drug side effect profile according report filed company funds necessary complete clinical development iloperidone currently pursuing several financing alternatives including corporate partnering arrangements balance sheet financing complete development iloperidone i assume vanda got involved i could find single published trial ilopderidone either pubmed clinicaltrials gov anybody direct me clinical trials data product i love see drug clinical trials phase development nearly decade published data show efficacy i impressed personal opinion better burning money investing vanda huge jump earlier week according reuters vanda received approvable letter fda concerns efficacy regarding iloperidone treatment schizophrenia ouch drug ludicrously named fiapta fanapta hello vanda shares dollar per share i initially warned everyone steer clear company stock always chance fda change heart possibly even worth buying point even obvious dogs day market occasionally corcept therapeutics i faith vanda products worth anything clinically i think might able bs enough analysts investors help drive price bucks per share note official investment advice